These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22463854)

  • 1. Intravitreal ranibizumab injection for choroidal neovascularization in Strümpell-Lorrain Syndrome.
    Tran TH; Baglin G; Querques G
    J Fr Ophtalmol; 2012 May; 35(5):353-5. PubMed ID: 22463854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.
    Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N
    Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal administration of ranibizumab for idiopathic choroidal neovascularization in a pregnant woman.
    Sarhianaki A; Katsimpris A; Petropoulos IK; Livieratou A; Theoulakis PE; Katsimpris JM
    Klin Monbl Augenheilkd; 2012 Apr; 229(4):451-3. PubMed ID: 22496030
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections.
    Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH
    Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal pigment epithelium tear formation following intravitreal ranibizumab injection in choroidal neovascularization secondary to choroidal osteoma.
    Erol MK; Coban DT; Ceran BB; Bulut M
    Cutan Ocul Toxicol; 2014 Sep; 33(3):259-63. PubMed ID: 24517498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravitreal ranibizumab for choroidal neovascularisation associated with adult-onset vitelliform dystrophy].
    Prieto-Calvo E; Torrón-Fernández Blanco C; Egea-Estopiñán C; Güerri-Monclús N; Ferrer-Novella E; Ruiz-Moreno O; Pablo-Julvez LE
    Arch Soc Esp Oftalmol; 2012 May; 87(5):149-52. PubMed ID: 22554558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration.
    Singer MA; Awh CC; Sadda S; Freeman WR; Antoszyk AN; Wong P; Tuomi L
    Ophthalmology; 2012 Jun; 119(6):1175-83. PubMed ID: 22306121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of inflammatory choroidal neovascularization (CNV) secondary to punctate inner choroidopathy in a young female of childbearing age with intra-vitreal ranibizumab and half-fluence photodynamic therapy (PDT) - a holistic approach.
    Cornish KS; Lim LT; Imrie F
    Semin Ophthalmol; 2012; 27(1-2):29-32. PubMed ID: 22352824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful management of choroidal metastasis with intravitreal ranibizumab injections.
    Detorakis ET; Agorogiannis G; Drakonaki EE; Tsilimbaris MK; Pallikaris IG
    Ophthalmic Surg Lasers Imaging; 2012 May; 43 Online():e47-51. PubMed ID: 22624796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination treatment with intravitreal injection of ranibizumab and reduced fluence photodynamic therapy for choroidal neovascularization secondary to angioid streaks: preliminary clinical results of 12-month follow-up.
    Artunay O; Yuzbasioglu E; Rasier R; Sengul A; Senel A; Bahcecioglu H
    Retina; 2011; 31(7):1279-86. PubMed ID: 21394063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiographic regression patterns after intravitreal ranibizumab injections for neovascular age-related macular degeneration.
    Tran TH; Querques G; Forzy G; Souied EH
    Ophthalmic Surg Lasers Imaging; 2011; 42(6):498-508. PubMed ID: 21830744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microperimetric retinal changes in myopic choroidal neovascularization treated with intravitreal ranibizumab.
    Varano M; Tedeschi M; Oddone F; Perillo L; Coppè AM; Parravano M
    Retina; 2010 Mar; 30(3):413-7. PubMed ID: 20010453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive response to intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to punctate inner choroidopathy.
    Menezo V; Cuthbertson F; Downes SM
    Retina; 2010 Oct; 30(9):1400-4. PubMed ID: 20224465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of vascular endothelial growth factor a in human breast milk after intravitreal injection of bevacizumab but not ranibizumab.
    Ehlken C; Martin G; Stahl A; Agostini HT
    Arch Ophthalmol; 2012 Sep; 130(9):1226-7. PubMed ID: 22965611
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravitreal ranibizumab for choroidal neovascularization complicating pathologic myopia.
    Lalloum F; Souied EH; Bastuji-Garin S; Puche N; Querques G; Glacet-Bernard A; Coscas G; Soubrane G; Leveziel N
    Retina; 2010 Mar; 30(3):399-406. PubMed ID: 20038864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to endogenous endophthalmitis.
    Sheu SJ
    Kaohsiung J Med Sci; 2009 Nov; 25(11):617-21. PubMed ID: 19858042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors of resolved retinal fluid after intravitreal ranibizumab for polypoidal choroidal vasculopathy.
    Koizumi H; Yamagishi T; Yamazaki T; Kinoshita S
    Br J Ophthalmol; 2011 Nov; 95(11):1555-9. PubMed ID: 21890787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of intravitreal ranibizumab, intravitreal ranibizumab with photodynamic therapy, and intravitreal triamcinolone with photodynamic therapy for the treatment of retinal angiomatous proliferation.
    Rouvas AA; Chatziralli IP; Theodossiadis PG; Moschos MM; Kotsolis AI; Ladas ID
    Retina; 2012 Jun; 32(6):1181-9. PubMed ID: 22466469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results.
    Monés JM; Amselem L; Serrano A; Garcia M; Hijano M
    Eye (Lond); 2009 Jun; 23(6):1275-80; quiz 1281. PubMed ID: 19478826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined reduced fluence photodynamic therapy and intravitreal ranibizumab for polypoidal choroidal vasculopathy.
    Ricci F; Calabrese A; Regine F; Missiroli F; Ciardella AP
    Retina; 2012 Jul; 32(7):1280-8. PubMed ID: 22218148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.